Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for DIVA Laboratories, Ltd. (4153.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
18.93
P/B ratioShare price divided by book value per share.
1.87
P/S ratioMarket value divided by annual revenue.
2.02
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
28.80%
Operating marginRevenue left after operating costs.
12.83%
Net marginRevenue left after every cost, including tax and interest.
10.73%
Return on equityProfit as a percentage of shareholders’ equity.
9.84%
Return on assetsProfit as a percentage of total assets.
4.34%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.41
Quick ratioThe same, excluding inventory.
1.79
Debt to equityTotal borrowings against shareholders’ equity.
0.00
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$1.63
Book value per shareShareholders’ equity divided by shares outstanding.
$16.49
Shares outstandingShares currently issued.
58,668,000
Market capitalisationShare price times shares outstanding.
$1.81B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
154
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
6.47%
Payout ratioShare of profit paid out as dividends.
DIVA Laboratories, Ltd. (4153.TWO) trades on a price-to-earnings ratio of 18.93.
What is DIVA Laboratories, Ltd.'s return on equity?
DIVA Laboratories, Ltd. (4153.TWO) reports a return on equity of 9.84%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does DIVA Laboratories, Ltd. carry?
DIVA Laboratories, Ltd. (4153.TWO) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.
What is DIVA Laboratories, Ltd.'s profit margin?
DIVA Laboratories, Ltd. (4153.TWO) keeps 10.73% of revenue as net profit after every cost, including tax and interest.